Assertio Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ASRT Nasdaq 2834 https://www.assertiotx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Assertio Therapeutics Inc

Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference - Aug 20th, 2019 6:00 am
Assertio Therapeutics Enters Oversold Territory - Aug 20th, 2019 5:59 am
ASRT vs. PCRX: Which Stock Is the Better Value Option? - Aug 19th, 2019 7:30 am
Assertio Therapeutics Inc (ASRT) Director, President and CEO Arthur J Higgins Bought $77,000 of ... - Aug 12th, 2019 7:15 pm
Assertio Therapeutics Announces Exchange Offer of $200 Million of its Currently Outstanding 2.50% Convertible Notes Due 2021 - Aug 9th, 2019 7:28 am
Assertio Therapeutics, Inc (ASRT) Q2 2019 Earnings Call Transcript - Aug 8th, 2019 9:24 pm
Assertio (ASRT) Q2 Earnings Beat Estimates - Aug 7th, 2019 5:35 pm
Assertio Therapeutics Announces Strong Second-Quarter 2019 Results - Aug 7th, 2019 2:02 pm
Is Assertio Therapeutics (NASDAQ:ASRT) A Risky Investment? - Aug 6th, 2019 1:22 pm
Assertio (ASRT) Earnings Expected to Grow: Should You Buy? - Jul 31st, 2019 8:36 am
ASRT or AMRX: Which Is the Better Value Stock Right Now? - Jul 26th, 2019 7:30 am
Assertio Therapeutics to Report Second Quarter 2019 Financial Results After The Close of Markets on Wednesday, August 7, 2019 - Jul 17th, 2019 2:05 pm
La Jolla (LJPC) Secures Positive CHMP Opinion for Giapreza - Jul 1st, 2019 6:39 am
Here’s What Hedge Funds Think About Assertio Therapeutics, Inc. (ASRT) - Jun 23rd, 2019 6:53 pm
Have Insiders Been Buying Assertio Therapeutics, Inc. (NASDAQ:ASRT) Shares? - Jun 22nd, 2019 8:37 am
See what the IHS Markit Score report has to say about Assertio Therapeutics Inc. - Jun 18th, 2019 6:03 am
Savara Plunges on Failure of Late-Stage Study on Molgradex - Jun 13th, 2019 7:50 am
ASSERTIO THERAPEUTICS Enters Oversold Territory - May 20th, 2019 8:28 am